액체 및 주사제 충전 기계 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Liquid & Injectable Filling Machinery Market was valued at USD 10.1 billion in 2025 and is estimated to grow at a CAGR of 6.7% to reach USD 19.2 billion by 2035.

The liquid & injectable filling machinery market is experiencing steady growth as pharmaceutical manufacturers, food and beverage companies, and cosmetics producers increasingly adopt advanced filling solutions to improve efficiency, accuracy, and compliance. The market is being shaped by two major demand trends: the modernization of sterile pharmaceutical manufacturing facilities and the accelerated adoption of automation across multiple processing industries. Growing investments in injectable therapies and stricter regulatory expectations for sterile production are encouraging manufacturers to upgrade filling equipment with advanced control systems and contamination prevention technologies. At the same time, industries across emerging regions are increasingly adopting automated filling machinery to improve productivity and maintain consistent quality standards. The transition from manual and semi-automated systems toward highly automated platforms is becoming a key industry shift as manufacturers focus on reducing operational risks, improving process reliability, and increasing production capacity. These developments are creating long-term growth opportunities for equipment suppliers offering flexible, digitally integrated, and high-performance filling solutions.

The liquid & injectable filling machinery market is undergoing a major transformation as pharmaceutical companies increasingly replace labor-intensive filling processes with automated systems designed to improve sterility assurance and operational efficiency. This shift is supported by rising regulatory expectations for advanced manufacturing practices, increased demand for injectable medicines, and the need for better control over critical production environments. Manufacturers are increasingly prioritizing equipment capable of supporting automated operations, improved monitoring, and enhanced process validation to meet evolving production requirements.

Automatic filling machines generated USD 6.48 billion in 2025 and is expected to grow at a CAGR of 7.7% from 2026 to 2035. The increasing preference for automated systems is driven by pharmaceutical requirements for controlled production processes, digital documentation, and automated quality management, along with the efficiency advantages demanded by high-volume manufacturing sectors. New investments are primarily focused on advanced equipment configurations that support liquid filling applications, improved production speed, and enhanced sterile processing capabilities.

The CMO/CDMO segment accounted USD 851 million in 2025 and is projected to grow at an 8.3% CAGR trough 2035. Contract manufacturing and development organizations require highly adaptable equipment solutions because they support multiple products and customers within shared manufacturing environments. These facilities demand advanced cleaning validation, sterilization capabilities, digital batch management systems, and operational flexibility to meet diverse customer quality requirements. The complexity of these specifications increases equipment value and creates stronger opportunities for OEM service and support offerings compared with single-product pharmaceutical manufacturing facilities.

North America Liquid & Injectable Filling Machinery Market held 27% share in 2025, supported by strong demand for pharmaceutical-grade aseptic filling technologies. Regulatory requirements surrounding sterile pharmaceutical manufacturing continue to influence equipment investments throughout the region, encouraging pharmaceutical companies to adopt advanced filling systems with enhanced automation, data management, and process control capabilities. Requirements related to electronic records, data integrity, and manufacturing compliance continue to shape the design and deployment of new filling machinery solutions across the U.S. pharmaceutical sector.

Major companies operating in the global liquid & injectable filling machinery market include Krones AG, Syntegon Technology GmbH, IMA Group, Tetra Pak International S.A., GEA Group AG, OPTIMA Packaging Group GmbH, KHS GmbH, Bausch+Strobel SE & Co. KG, groninger & co. gmbh, Serac Group, Sidel Group, Marchesini Group S.p.A., Rommelag, ProMach Inc., NKP Pharma Pvt. Ltd., Lodha International LLP, Ambica Pharma Machines Pvt. Ltd., Snowbell Machines Pvt. Ltd., Cozzoli Machine Company, AST, and Dara Pharma S.L. Companies operating in the liquid & injectable filling machinery market are strengthening their market position through continuous product development, automation upgrades, and expansion of advanced manufacturing capabilities. Market participants are investing in smart filling technologies, digital monitoring systems, and flexible equipment platforms to address changing customer needs across pharmaceutical and industrial sectors. Strategic partnerships, global service networks, and customized equipment solutions are helping companies improve customer relationships and expand their presence across key regions.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Research approach
• 1.2 Quality Commitments
  • 1.2.1 GMI AI policy & data integrity commitment
  • 1.2.2 Source consistency protocol
• 1.3 Research Trail & Confidence Scoring
  • 1.3.1 Research Trail Components
  • 1.3.2 Scoring Components
• 1.4 Data Collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Region
  • 2.2.2 Machine Type
  • 2.2.3 Filling Technology
  • 2.2.4 Container Type
  • 2.2.5 Fill Type
  • 2.2.6 End-use Industry
  • 2.2.7 Output/Throughput Capacity
  • 2.2.8 Distribution channel

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Profit margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Surging demand for biologics, mRNA vaccines & sterile injectables driving aseptic filling line investments
    • 3.2.1.2 EU GMP Annex 1 revision (2023) mandating isolator & environmental monitoring upgrades across European pharma facilities
    • 3.2.1.3 Industry 4.0 adoption - AI, IoT, digital twins & servo automation improving throughput & reducing downtime
    • 3.2.1.4 Expansion of CMO/CDMO capacity globally creating sustained demand for multi-format filling systems
    • 3.2.1.5 Rising prefilled syringe & auto-injector demand (GLP-1 agonists, oncology, insulin) requiring high-precision filling equipment
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High capital investment for aseptic, isolator-integrated & high-speed filling systems limiting SME adoption
    • 3.2.2.2 Complex & divergent validation requirements across FDA, EMA & PMDA increasing engineering hours & delaying site acceptance tests
    • 3.2.2.3 Skilled workforce shortage
    • 3.2.2.4 Supply chain vulnerabilities in critical components
  • 3.2.3 Opportunities
    • 3.2.3.1 Personalized medicine & small-batch flexible filling
    • 3.2.3.2 Emerging market pharma infrastructure build-out (India, Southeast Asia, MEA) creating new equipment procurement pipelines
    • 3.2.3.3 Single-use filling technology expansion
    • 3.2.3.4 BFS (blow-fill-seal) technology adoption in sterile ophthalmic & respiratory drug packaging
• 3.3 Growth potential analysis
• 3.4 Supply Chain Analysis
  • 3.4.1 Critical Component Sourcing
  • 3.4.2 Single-Source vs. Multi-Source Supplier Strategies
  • 3.4.3 Nearshoring & Reshoring Trends in Machinery Supply Chains
  • 3.4.4 Lead Time Analysis & Procurement Risk Assessment
• 3.5 Future market trends
• 3.6 Technology and innovation landscape
  • 3.6.1 Current technological trends
  • 3.6.2 Emerging technologies
• 3.7 Regulatory landscape
  • 3.7.1 FDA cGMP & 21 CFR Part 11 (Electronic Records) Requirements
  • 3.7.2 EU GMP Annex 1 (2023 Revision)
  • 3.7.3 PMDA (Japan) Regulatory Requirements for Injectable Filling
  • 3.7.4 WHO Prequalification Standards for Vaccine Filling Equipment
  • 3.7.5 ICH Q12 Harmonization Progress & Equipment Validation Impact
  • 3.7.6 Emerging Market Regulatory Frameworks (India CDSCO, China NMPA)
• 3.8 Trade data analysis
  • 3.8.1 Import/Export Volume & Value Trends by Machine Category (Driven by Primary Research)
  • 3.8.2 Key Trade Corridors & Tariff Impact (EU to Asia, US to LATAM) (Driven by Primary Research)
  • 3.8.3 HS Code Classification - 8422.30 (Machinery for Filling, Closing, Sealing)
• 3.9 Impact of AI & generative AI on the market
  • 3.9.1 AI-Driven Disruption of Existing Filling Line Architectures
  • 3.9.2 GenAI Use Cases & Adoption Roadmap by Segment (Pharma vs. F&B vs. Cosmetics)
  • 3.9.3 Predictive Maintenance, Nozzle Calibration & Process Optimization via AI
  • 3.9.4 Risks, Limitations & Regulatory Considerations (GAMP 5, Data Integrity)
• 3.10 Pricing Analysis
  • 3.10.1 Pricing Strategy by Player Type (Premium / Value / Cost-plus) (Driven by Primary Research)
  • 3.10.2 Price Benchmarking by Machine Type
  • 3.10.3 Total Cost of Ownership (TCO) Analysis
• 3.11 Porter's analysis
• 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates & Forecast, By Machine Type, 2022 - 2035, (USD Billion) (Million Units)

• 5.1 Key Trends
• 5.2 Automatic Filling Machines
  • 5.2.1 Rotary Automatic Filling Machines
  • 5.2.2 Inline/Linear Automatic Filling Machines
  • 5.2.3 Monobloc (Rinse-Fill-Cap) Automatic Systems
• 5.3 Semi-Automatic Filling Machines
  • 5.3.1 Benchtop Semi-Automatic Filling Machines
  • 5.3.2 Floor-Standing Semi-Automatic Filling Machines
• 5.4 Manual Filling Machines
  • 5.4.1 Handheld & Bench-Top Manual Fillers
  • 5.4.2 Gravity-Fed Manual Dispensing Systems

Chapter 6 Market Estimates & Forecast, By Filling Technology, 2022 - 2035, (USD Billion) (Million Units)

• 6.1 Key Trends
• 6.2 Piston Filling
  • 6.2.1 Single-Acting Piston Filling
  • 6.2.2 Double-Acting Piston Filling
• 6.3 Peristaltic/Pump Filling
  • 6.3.1 Servo Peristaltic Pump Filling
  • 6.3.2 Standard Peristaltic Pump Filling
• 6.4 Overflow Filling
• 6.5 Gravity/Time-Gravity Filling
• 6.6 Net Weight/Gravimetric Filling
• 6.7 Vacuum Filling
• 6.8 Time-Pressure Filling
• 6.9 Others (Mass Flow Meter, Corrosive Liquid, Servo Pump)

Chapter 7 Market Estimates & Forecast, By Container Type, 2022 - 2035, (USD Billion) (Million Units)

• 7.1 Key Trends
• 7.2 Vials & Ampoules
  • 7.2.1 Glass Vials
  • 7.2.2 Plastic/Polymer Vials
  • 7.2.3 Glass Ampoules
• 7.3 Prefilled Syringes
  • 7.3.1 Glass Prefilled Syringes
  • 7.3.2 Plastic/COC/COP Prefilled Syringes
• 7.4 Cartridges
  • 7.4.1 Insulin & Pen-Injector Cartridges
  • 7.4.2 Auto-Injector Cartridges
• 7.5 Bottles & Jars
  • 7.5.1 Glass Bottles
  • 7.5.2 Plastic (PET/HDPE) Bottles
  • 7.5.3 Jars (Cosmetic & Food Grade)
• 7.6 Pouches & Sachets
  • 7.6.1 Flexible Pouches (Stand-Up & Flat)
  • 7.6.2 Single-Dose Sachets
• 7.7 Bags (IV Bags & Bag-in-Box)
  • 7.7.1 Large Volume Parenteral (LVP) IV Bags
  • 7.7.2 Industrial Bag-in-Box Formats
• 7.8 Others (Tubes, Cans, Drums & Bulk Containers)

Chapter 8 Market Estimates & Forecast, By Fill Type, 2022 - 2035, (USD Billion) (Million Units)

• 8.1 Key Trends
• 8.2 Aseptic Filling
  • 8.2.1 Isolator-Based Aseptic Filling
  • 8.2.2 RABS (Restricted Access Barrier System)
  • 8.2.3 Blow-Fill-Seal (BFS) Aseptic Filling
• 8.3 Cold Filling
  • 8.3.1 Ambient Cold Filling (Chemical Preservatives)
  • 8.3.2 Refrigerated Cold Filling (Carbonated & Sensitive Beverages)
• 8.4 Hot/Warm Filling
  • 8.4.1 Hot Fill (>85°C)
  • 8.4.2 Warm Fill (65-85°C)

Chapter 9 Market Estimates & Forecast, By End-use Industry, 2022 - 2035, (USD Billion) (Million Units)

• 9.1 Key Trends
• 9.2 Pharmaceutical & Biotech
  • 9.2.1 Small Molecule Drugs (Injectable & Oral Liquid)
  • 9.2.2 Biologics (Monoclonal Antibodies, Biosimilars)
  • 9.2.3 Vaccines (Vial & Prefilled Syringe Format)
  • 9.2.4 Ophthalmic & Respiratory Drugs
• 9.3 Contract Manufacturing Organizations (CMOs/CDMOs)
  • 9.3.1 Large CMOs (Multi-Product Commercial-Scale)
  • 9.3.2 Specialty/Niche CDMOs (Biologics & High-Potency)
• 9.4 Food & Beverages
  • 9.4.1 Non-Alcoholic Beverages (Water, Juices, RTD)
  • 9.4.2 Alcoholic Beverages (Wine, Spirits, Beer)
  • 9.4.3 Dairy & Liquid Food (Sauces, Oils, Condiments)
• 9.5 Cosmetics & Personal Care
  • 9.5.1 Skincare (Serums, Lotions, Creams)
  • 9.5.2 Haircare (Shampoos, Conditioners, Oils)
  • 9.5.3 Fragrance & Color Cosmetics
• 9.6 Chemical & Industrial
  • 9.6.1 Agrochemicals & Pesticides
  • 9.6.2 Household Cleaning & Detergents
  • 9.6.3 Lubricants & Industrial Fluids
• 9.7 Others (Nutraceuticals, Veterinary, Oil & Gas)

Chapter 10 Market Estimates & Forecast, By Output/Throughput Capacity, 2022 - 2035, (USD Billion) (Million Units)

• 10.1 Key Trends
• 10.2 Low Output (Up to 100 Fills/Hr)
• 10.3 Medium Output (101-500 Fills/Hr)
• 10.4 High Output (501-1,000 Fills/Hr)
• 10.5 Very High Output (Above 1,000 Fills/Hr)

Chapter 11 Market Estimates & Forecast, By Distribution Channel, 2022 - 2035, (USD Billion) (Million Units)

• 11.1 Key Trends
• 11.2 Direct
• 11.3 Indirect

Chapter 12 Market Estimates & Forecast, By Region, 2022 - 2035, (USD Billion) (Million Units)

• 12.1 Key Trends
• 12.2 North America
  • 12.2.1 U.S.
  • 12.2.2 Canada
• 12.3 Europe
  • 12.3.1 Germany
  • 12.3.2 France
  • 12.3.3 UK
  • 12.3.4 Italy
  • 12.3.5 Spain
• 12.4 Asia Pacific
  • 12.4.1 China
  • 12.4.2 Japan
  • 12.4.3 India
  • 12.4.4 Australia
  • 12.4.5 South Korea
• 12.5 Latin America
  • 12.5.1 Brazil
  • 12.5.2 Mexico
  • 12.5.3 Argentina
• 12.6 MEA
  • 12.6.1 Saudi Arabia
  • 12.6.2 UAE
  • 12.6.3 South Africa

Chapter 13 Company Profiles

• 13.1 Global Leaders
  • 13.1.1 Syntegon Technology GmbH
  • 13.1.2 Krones AG
  • 13.1.3 IMA Group
  • 13.1.4 GEA Group AG
  • 13.1.5 Tetra Pak International S.A.
  • 13.1.6 KHS GmbH
  • 13.1.7 OPTIMA Packaging Group GmbH
• 13.2 Regional Players
  • 13.2.1 groninger & co. gmbh
  • 13.2.2 Bausch+Strobel SE & Co. KG
  • 13.2.3 Serac Group
  • 13.2.4 Sidel Group
  • 13.2.5 Marchesini Group S.p.A.
  • 13.2.6 Rommelag
  • 13.2.7 ProMach Inc.
• 13.3 Emerging Players
  • 13.3.1 NKP Pharma Pvt. Ltd.
  • 13.3.2 Lodha International LLP
  • 13.3.3 Ambica Pharma Machines Pvt. Ltd.
  • 13.3.4 Snowbell Machines Pvt. Ltd.
  • 13.3.5 Cozzoli Machine Company
  • 13.3.6 AST
  • 13.3.7 Dara Pharma S.L.